What is the recommended treatment for tinea unguium (fungal infection of the nail)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Tinea Unguium (Fungal Nail Infection)

Oral terbinafine is the first-line treatment for tinea unguium (onychomycosis) due to its superior efficacy and relatively low risk of side effects. 1

Systemic Treatment Options

First-line Treatment

  • Terbinafine
    • Dosage: 250 mg once daily 2
    • Duration: 6 weeks for fingernails, 12 weeks for toenails 2
    • Efficacy: Mycological cure rates of 73-94% 1
    • Mechanism: Inhibits squalene epoxidase, essential for fungal cell wall synthesis 3
    • Prior to treatment: Confirm diagnosis with KOH preparation, fungal culture, or nail biopsy 2
    • Monitoring: Baseline liver function tests recommended; discontinue if liver injury develops 2
    • Side effects: Headache, taste disturbance, gastrointestinal upset 1

Alternative Systemic Treatments

  • Itraconazole

    • Recommended for Candida infections and nondermatophyte molds 1
    • Dosage: 200 mg daily continuous therapy or pulse therapy for 12 weeks 1
    • Efficacy: Mycological cure rate of 45.8% at 48 weeks 1
    • Broader antimicrobial coverage than terbinafine 1
    • Higher risk of drug interactions than terbinafine 1
  • Fluconazole

    • Dosage: 150-450 mg once weekly for at least 6 months for toenail infections 1
    • Useful alternative when patients cannot tolerate terbinafine or itraconazole 1
  • Griseofulvin (less preferred)

    • Dosage: 500-1000 mg daily 4
    • Duration: At least 4 months for fingernails, at least 6 months for toenails 4
    • Lower efficacy (3-38% for toenails) and higher relapse rates compared to newer agents 5, 1
    • Only antifungal agent specifically licensed for children with onychomycosis 3
    • Pediatric dosage: 10 mg/kg daily 4

Topical Treatment Options

Topical therapy should only be used in superficial white onychomycosis, very early distal lateral subungual onychomycosis, or when systemic therapy is contraindicated 3.

  • Amorolfine 5% nail lacquer

    • Application: Once or twice weekly 3
    • Efficacy: Approximately 50% in distal nail infections 3, 1
    • Duration: 6-12 months 3
  • Ciclopirox 8% lacquer

    • Application: Once daily 3
    • Duration: Up to 24 weeks for fingernails, up to 48 weeks for toenails 3
    • Efficacy: Mycological cure rates of 34% 1
  • Efinaconazole 10% solution

    • Application: Once daily 3
    • Efficacy: Mycological cure rates of 50% 1
  • Tioconazole 28% solution

    • Lower efficacy than other topical options 3
    • Contraindicated in pregnancy 1

Treatment Algorithm

  1. Confirm diagnosis with KOH preparation, fungal culture, or nail biopsy
  2. Assess infection severity and causative organism:
    • For dermatophyte infections (most common): Terbinafine is first choice
    • For Candida or nondermatophyte molds: Consider itraconazole
  3. Consider patient factors:
    • Hepatic impairment: Avoid terbinafine, itraconazole, and griseofulvin; consider fluconazole with dose adjustment 1
    • Heart failure: Avoid itraconazole 1
    • High risk of drug interactions: Prefer terbinafine over azoles 1
    • Children: Use weight-based dosing of terbinafine or griseofulvin 1, 4
  4. For mild cases or when oral therapy is contraindicated: Use topical therapy
  5. For severe or resistant cases: Consider combination therapy (oral + topical) or surgical approaches

Management of Treatment Failure

If treatment fails, consider:

  • Poor compliance
  • Poor drug absorption
  • Immunosuppression
  • Dermatophyte resistance
  • Subungual dermatophytoma
  • Zero nail growth 1

Options include:

  • Switching to an alternative antifungal drug
  • Partial nail removal plus antifungal therapy
  • Complete nail avulsion combined with antifungal therapy 1

Prevention of Recurrence

Onychomycosis has high recurrence rates (40-70%) even with established treatments 1. Preventive measures include:

  • Keeping nails short
  • Avoiding sharing nail clippers
  • Wearing protective footwear in public areas
  • Applying antifungal powders in shoes and on feet
  • Wearing cotton, absorbent socks
  • Treating concomitant fungal infections 1

The optimal clinical effect is seen some months after mycological cure and cessation of treatment, as this relates to the period required for outgrowth of healthy nail 2.

References

Guideline

Onychomycosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.